I

IBEX

Biotech company: antibodies and gene therapy

Bilingual Customer Service Representative

Full-TimeDeadline 5/20/27
No salary listed
Junior
Charleston, WV, USA
RemoteRemote work is limited to eligible U.S. states listed in the posting; a private workspace and hard-wired internet connection are required.
Customer Experience & SupportCustomer Support

About the job

Requirements
  • Fluency in both English and Spanish, including the ability to accurately translate and communicate medical terminology.
  • A high school diploma or equivalent.
  • Two years of experience in a customer service environment.
  • Ability to multitask using multiple applications simultaneously.
  • Ability to set up computer equipment and troubleshoot issues with minimal assistance.
  • Professional verbal and written communication skills.
  • Ability to operate a computer and knowledge of Microsoft Office applications.
  • Strong organizational skills and attention to detail.
  • Ability to work independently and with a team.
  • Ability to learn quickly and adapt to a fast-paced production environment.
  • Cooperative, professional, and effective interaction skills.
  • Critical thinking and problem-solving skills.
  • Ability to tolerate repetitive work without compromising accuracy and service levels.
  • Ability to attend additional training as requested or deemed necessary.
  • For work at home, a private, distraction-free workspace is required.
  • For work at home, a hard-wired Ethernet internet connection with minimum speeds of 50 Mbps download and 10 Mbps upload is required; 5G, hotspots, and satellite internet are not supported.
  • Active wireless phone service is required for work at home.
  • Must remain on camera during working hours.
  • Candidates must reside in one of the eligible states listed in the posting.
Responsibilities
  • Answer general customer inquiries, address concerns, and assist with product and service requests across multiple lines of business and customer contact channels.
  • Resolve coordination of benefits inquiries by analyzing patient activity, including enrollment, third-party liability, and claims attachments.
  • Understand insurance coverage and interpret and communicate accurate information.
  • Thoroughly document all customer interactions.
  • Educate customers and dental professionals on eligibility, benefits, claims payment, and authorizations.
  • Educate customers on the usage and benefits of self-service tools.
  • Assist members in gaining access to care by locating a network dentist or assigning a primary care dentist.
  • Direct inquiries to the necessary departments or individuals when the resolution is beyond the role's scope of control.
  • Respond to customer inquiries in a courteous and professional manner.
  • Research and provide accurate information to resolve member and provider inquiries through verbal and written communications across phone, email, web portal, and chat channels.
  • Respond to and resolve complex internal and external customer inquiries.
  • Resolve claim payment inquiries by researching and analyzing patient activity and determining the appropriate action.
  • Take ownership of resolutions and set expectations for follow-up.
  • Ensure resubmissions, stop payments, and voids are handled appropriately.
  • Meet or exceed individual, department, and client-specific goals.
  • Understand and adhere to client administrative and contractual policies and procedures.
  • Suggest ways to improve service delivery processes.
  • Perform other duties as assigned.
Desired Qualifications
  • Experience in healthcare or a related industry.
  • Knowledge of medical and dental terminology.
  • Knowledge of Medicare and Medicaid.
  • Claims, billing, and coding experience.

About the company

Ibex Biosciences focuses on discovering, validating, and producing biotechnology solutions for health and ecological challenges. Its product portfolio includes therapeutic antibodies, gene therapy, and stem cell programs, as well as diagnostic antibodies for Immunohistochemistry (IHC) to improve biopsy accuracy. The company advances its products by conducting exploratory R&D on projects that may not yet be validated in public research, then develops and commercializes these technologies through licensing, partnerships, and direct sales to healthcare and research institutions. A key differentiator is Ibex’s diversified, internally driven pipeline and its mix of therapeutics and diagnostics, alongside active engagement in grant funding and patenting. The company’s goal is to bring proprietary biotech innovations to market to enhance patient outcomes and health-related research, addressing significant cancer-related and other health challenges.

Company Size

1-10

Company Stage

Early VC

Total Funding

$4.2M

Headquarters

North Bethesda, Maryland

Founded

2015

Get referred to IBEX

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Ibex keeps an open 506(c) offering, signaling active capital formation in 2026.
  • The 2022 CD147 patent supports oncology and inflammation licensing conversations.
  • Anti-MIF VHH development continues, with animal-model testing already disclosed.

What critics are saying

  • Ibex has no disclosed commercial products, leaving revenue dependent on financing.
  • The open Regulation D offering implies dilution risk and financing pressure through 2026.
  • Without clinical validation, the company risks becoming a perpetual patent shop.

What makes IBEX unique

  • North Bethesda-based Ibex Biosciences focuses on antibody, gene-therapy, and stem-cell programs.
  • Its 2026 pipeline spans CD147 antibodies, anti-MIF VHHs, and PCBP1 stem-cell methods.
  • Ibex still controls early patentable assets, including 2022 CD147 publication.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

Company News

Ibex Innovations
Mar 12th, 2025
IBEX Completes £2m Fundraise for Osteoporosis

IBEX has successfully completed a £2 million funding round to advance its mission of using X-ray technology to diagnose osteoporosis early. The company aims to shift from reactive to proactive treatment of this silent disease. With partnerships established with X-ray and mammography OEMs in 2024, IBEX plans to deploy its technology in clinical settings by 2025, demonstrating cost savings for the NHS.

Globes
Feb 8th, 2022
Gauzy acquires Vision Systems

Israeli light control nanotech and smart glass company Gauzy has announced that it has acquired French company Vision Systems, which develops ADAS (Advanced Driver Assistance System) and shading solutions for the aeronautic, land transport, and marine industries.